Govt bans 156 cocktail medicines that include antibiotics, painkillers and multivitamins

The government on Thursday banned 156 fixed-dose combination medicines, including antibiotics used for fever and colds, painkillers, and multivitamins, saying that they are ‘likely to involve risk to human beings’

Fixed-dose combination (FDC) drugs are medicines that contain a combination of two or more active pharmaceutical ingredients in a fixed ratio. They are also referred to as “cocktail” drugs.

Issuing a gazette notification prohibiting the manufacture, sale and distribution of these medicinesunder section 26 A of the Drugs and Cosmetics Act 1940, the Union health ministry said, “The matter was examined by an expert committee appointed by the central government and the DTAB, with both bodies recommending that there is no therapeutic justification for the ingredients contained in the said FDCs.”

The ban list includes “Aceclofenac 50mg + Paracetamol 125mg tablet.” This is one of the popular combinations of pain-relieving medicines manufactured by top pharmaceutical companies.

The list also includes Mefenamic Acid Paracetamol Injection, Cetirizine HCl Paracetamol Phenylephrine HCl, Levocetirizine Phenylephrine HCl Paracetamol, Paracetamol Chlorpheniramine Maleate Phenyl Propanolamine and Camylofin Dihydrochloride 25 mg Paracetamol 300mg.

The government also banned the combination of Paracetamol, Tramadol, Taurine and Caffeine. Tramadol is an opioid-based painkiller.

“The Central government is satisfied that the use of the Fixed Dose Combination drug is likely to involve risk to human beings whereas safer alternatives to the said drug are available,” the notification said.

It said that the matter was examined by an Expert Committee appointed by the Centre, which considered these FDCs as “irrational”.

The notification further said that “the Central government is satisfied that it is necessary and expedient in public interest to prohibit the manufacture, sale and distribution for human use of the said drug in the country”.

The list also includes certain products that many drug makers have already discontinued. In June 2023, 14 FDCs, which were part of those 344 drug combinations, were banned.

In 2016, the government announced the ban on the manufacture, sale, and distribution of 344 drug combinations after the recommendations of an expert panel set up at the Supreme Court’s behest.

Related Posts

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines